ICON EBIT 2010-2023 | ICLR

ICON annual and quarterly EBIT history from 2010 to 2023. EBIT can be defined as earnings before interest and taxes.
  • ICON EBIT for the quarter ending December 31, 2023 was $0.266B, a 30.59% increase year-over-year.
  • ICON EBIT for the twelve months ending December 31, 2023 was $0.956B, a 20.23% increase year-over-year.
  • ICON 2023 annual EBIT was $0.956B, a 20.23% increase from 2022.
  • ICON 2022 annual EBIT was $0.795B, a 110.09% increase from 2021.
  • ICON 2021 annual EBIT was $0.379B, a 3.31% decline from 2020.
ICON Annual EBIT
(Millions of US $)
2023 $956
2022 $795
2021 $379
2020 $392
2019 $433
2018 $373
2017 $338
2016 $312
2015 $282
2014 $202
2013 $121
2012 $68
2011 $39
2010 $92
2009 $116
ICON Quarterly EBIT
(Millions of US $)
2023-12-31 $266
2023-09-30 $264
2023-06-30 $209
2023-03-31 $217
2022-12-31 $203
2022-09-30 $244
2022-06-30 $178
2022-03-31 $170
2021-12-31 $145
2021-09-30 $5
2021-06-30 $113
2021-03-31 $116
2020-12-31 $120
2020-09-30 $108
2020-06-30 $57
2020-03-31 $106
2019-12-31 $115
2019-09-30 $110
2019-06-30 $106
2019-03-31 $102
2018-12-31 $102
2018-09-30 $98
2018-06-30 $82
2018-03-31 $92
2017-12-31 $90
2017-09-30 $85
2017-06-30 $78
2017-03-31 $86
2016-12-31 $85
2016-09-30 $77
2016-06-30 $74
2016-03-31 $76
2015-12-31 $75
2015-09-30 $71
2015-06-30 $68
2015-03-31 $67
2014-12-31 $52
2014-09-30 $59
2014-06-30 $48
2014-03-31 $43
2013-12-31 $30
2013-09-30 $33
2013-06-30 $31
2013-03-31 $130
2012-12-31 $19
2012-09-30 $21
2012-06-30 $17
2012-03-31 $102
2011-12-31 $7
2011-09-30 $1
2011-06-30 $16
2011-03-31 $92
2010-12-31 $112
2010-09-30 $18
2010-06-30 $26
2010-03-31 $27
2009-12-31 $30
2009-09-30 $30
2009-06-30 $29
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Services $24.881B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $121.982B 15.31
Cencora (COR) United States $45.721B 17.82
DiDi Global (DIDIY) China $23.865B 0.00
Avantor (AVTR) United States $16.588B 24.42
Viatris (VTRS) United States $13.847B 3.98
CochLear (CHEOY) Australia $13.505B 0.00
Revvity (RVTY) United States $12.674B 22.21
Medpace Holdings (MEDP) United States $12.327B 40.56
Charles River Laboratories (CRL) United States $11.986B 21.85
Natera (NTRA) United States $11.509B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $11.385B 0.00
Solventum (SOLV) United States $11.239B 0.00
Sonic Healthcare (SKHHY) Australia $8.205B 0.00
HealthEquity (HQY) United States $6.843B 51.12
Organon (OGN) United States $4.843B 4.66
Bausch + Lomb (BLCO) Canada $4.828B 19.35
Doximity (DOCS) United States $4.479B 33.35
PACS (PACS) United States $3.736B 0.00
Sotera Health (SHC) United States $3.190B 15.65
Surgery Partners (SGRY) United States $3.131B 28.98
Progyny (PGNY) United States $3.103B 52.08
GoodRx Holdings (GDRX) United States $2.753B 139.40
Life Times (LTH) United States $2.557B 27.08
Premier (PINC) United States $2.523B 9.24
AMN Healthcare Services Inc (AMN) United States $2.270B 7.34
Teladoc Health (TDOC) United States $2.172B 0.00
Agilon Health (AGL) United States $2.039B 0.00
BrightSpring Health Services (BTSG) United States $1.825B 0.00
Establishment Labs Holdings (ESTA) $1.390B 0.00
Agiliti (AGTI) United States $1.374B 22.44
NovoCure (NVCR) Jersey $1.371B 0.00
Alignment Healthcare (ALHC) United States $0.995B 0.00
Pediatrix Medical (MD) United States $0.757B 7.83
Embecta (EMBC) United States $0.583B 3.85
GeneDx Holdings (WGS) United States $0.545B 0.00
InnovAge Holding (INNV) United States $0.527B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.525B 0.00
Auna S.A (AUNA) Luxembourg $0.517B 0.00
Enhabit (EHAB) United States $0.511B 46.27
LifeMD (LFMD) United States $0.476B 0.00
CareDx (CDNA) United States $0.475B 0.00
Sonida Senior Living (SNDA) United States $0.448B 0.00
MultiPlan (MPLN) United States $0.414B 0.00
Beauty Health (SKIN) United States $0.391B 0.00
DocGo (DCGO) United States $0.353B 56.50
Sera Prognostics (SERA) United States $0.338B 0.00
ModivCare (MODV) United States $0.317B 4.20
Sharecare (SHCR) United States $0.263B 0.00
Ascend Wellness Holdings (AAWH) United States $0.260B 0.00
Biodesix (BDSX) United States $0.143B 0.00
So-Young (SY) China $0.127B 42.67
Oncology Institute (TOI) United States $0.083B 0.00
Pono Capital Two (PTWO) United States $0.071B 0.00
IceCure Medical (ICCM) Israel $0.053B 0.00
NeueHealth (NEUE) United States $0.051B 0.00
Co-Diagnostics (CODX) United States $0.037B 0.00
SeaStar Medical Holding (ICU) United States $0.035B 0.00
Singular Genomics Systems (OMIC) United States $0.030B 0.00
Nutex Health (NUTX) United States $0.030B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
DermTech (DMTK) United States $0.021B 0.00
OncoCyte (OCX) United States $0.021B 0.00
BIMI Holdings (BIMI) United States $0.014B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
NewGenIvf Group (NIVF) Singapore $0.006B 0.00
OpGen (OPGN) United States $0.005B 0.00
Assure Holdings (IONM) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00